Search results for "DEFICIENCY"

showing 10 items of 1071 documents

Demonstration of antibodies to the surface (anti-p41) and core proteins (anti-p24) of the human immunodeficiency virus (HIV) in individuals positive …

1987

Diagnosis of infection with the human immunodeficiency virus (HIV) relies on the demonstration of antibody to this virus. Occasionally, the combined analysis of sera using ELISA and western blot reveals false-positive results. We have compared a newly developed test to detect antibodies to the core (anti-p24) and surface (anti-p41) proteins of HIV with the established tests described above. Anti-p24 and anti-p41 were negative in three individuals positive for anti-HIV by ELISA and immunoblot; they had a low risk to acquire HIV infection and were clinically and immunologically normal and suspected false positive previously. In 62 individuals at risk, anti-p41 was always positive while anti-p…

MaleRiskRetroviridae Proteins OncogenicHuman immunodeficiency virus (HIV)Retroviridae ProteinsEnzyme-Linked Immunosorbent AssayHIV Antibodiesmedicine.disease_causeAntibodies ViralVirusAcquired immunodeficiency syndrome (AIDS)Western blotViral Envelope ProteinsAntibody SpecificityDrug DiscoverymedicineHumansGenetics (clinical)Acquired Immunodeficiency Syndromebiologymedicine.diagnostic_testAnti hivvirus diseasesHIVCore proteinGeneral Medicinemedicine.diseaseVirologyHIV Envelope Protein gp41Immunologybiology.proteinMolecular MedicineFemaleAntibodyKlinische Wochenschrift
researchProduct

Where are patients missed in the tuberculosis diagnostic cascade? A prospective cohort study in Ghana.

2020

BackgroundGhana's national prevalence survey showed higher than expected tuberculosis (TB) prevalence, indicating that many people with TB are not identified and treated. This study aimed to identify gaps in the TB diagnostic cascade prior to starting treatment.MethodsA prospective cohort study was conducted in urban and rural health facilities in south-east Ghana. Consecutive patients routinely identified as needing a TB test were followed up for two months to find out if sputum was submitted and/or treatment started. The causal effect of health facility location on submitting sputum was assessed before risk factors were investigated using logistic regression.ResultsA total of 428 persons …

MaleRural PopulationBacterial DiseasesRNA virusesResearch FacilitiesUrban PopulationPhysiologyHIV InfectionsPathology and Laboratory MedicineGhanaCohort StudiesGeographical Locations0302 clinical medicineImmunodeficiency VirusesHealth facilityHealth careOdds RatioMedicine and Health SciencesCoughingProspective Studies030212 general & internal medicineProspective cohort studyMultidisciplinaryRural healthQRMiddle AgedBody FluidsInfectious DiseasesMedical MicrobiologyResearch DesignViral PathogensVirusesTuberculosis Diagnosis and ManagementMedicineFemaleAnatomyPathogensmedicine.symptomResearch LaboratoriesResearch ArticleCohort studyAdultmedicine.medical_specialtyTuberculosisAdolescentScience030231 tropical medicineResearch and Analysis MethodsMicrobiologyYoung Adult03 medical and health sciencesSigns and SymptomsTuberculosis diagnosisDiagnostic MedicineRetrovirusesmedicineHumansTuberculosisMicrobial PathogensAgedbusiness.industryLentivirusSputumOrganismsBiology and Life SciencesHIVTropical Diseasesmedicine.diseaseMucusFamily medicinePeople and PlacesAfricaSputumHealth FacilitiesPhysiological ProcessesbusinessGovernment LaboratoriesPLoS ONE
researchProduct

Different neighborhood walkability indexes for active commuting to school are necessary for urban and rural children and adolescents

2020

This work was supported by the Spanish Ministry of Economy, Industry and Competitiveness and the European Regional Development Fund [grant no. DEP2016-75598-R, MINECO/FEDER, UE]. Additionally, this study takes place thanks to the funding from the University of Granada Plan Propio de Investigacion 2016 -Excellence actions: Unit of Excellence on Exercise and Health (UCEES) -and the Junta de Andalucia, Consejeria de Conocimiento, Investigacion y Universidades, European Regional Development Fund [grant no. SOMM17/6107/UGR]. The funding body had no role in the study design or collection, analysis, or interpretation of the data or in writing the manuscript.

MaleRural PopulationYouthAdolescentUrban PopulationPsychological interventionMedicine (miscellaneous)Behavioural sciencesPoison controlPhysical Therapy Sports Therapy and RehabilitationTransportationWalkingPhysical environmentResidence CharacteristicsEnvironmental healthHumansMAPS-global toolBuilt EnvironmentChildlcsh:RC620-627Built environmentNutrition and DieteticsSchoolsSchool active travelPhysical activityResearchlcsh:Public aspects of medicineHuman factors and ergonomicslcsh:RA1-1270Health equitylcsh:Nutritional diseases. Deficiency diseasesGeographyCross-Sectional StudiesWalkabilitySpainFemaleTraffic calmingHealth disparitiesActive transport
researchProduct

Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital

2010

Published version of an article from the journal: Journal of Antimicrobial Chemotherapy. Also available from the publisher: htttp://dx.doi.org/10.1093/jac/dkq234 Objectives: To assess long-term virological efficacy and the emergence of drug resistance in children who receive antiretroviral treatment (ART) in rural Tanzania. Patients and methods: Haydom Lutheran Hospital has provided ART to HIV-infected individuals since 2003. From February through May 2009, a cross-sectional virological efficacy survey was conducted among children (, 15 years) who had completed >= 6 months of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based ART. Genotypic resistance was determined in …

MaleRural Populationsub-Saharan AfricaMicrobiology (medical)medicine.medical_specialtyAdolescentGenotypeantiretroviral therapyPopulationVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Communicable diseases: 776Drug resistanceTanzaniaPharmacotherapyAcquired immunodeficiency syndrome (AIDS)Drug Resistance ViralAntimicrobial chemotherapyPrevalencemedicineHumansPharmacology (medical)educationOriginal ResearchPharmacologychildeducation.field_of_studyVDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin sosialmedisin: 801biologybusiness.industryHIVLamivudineViral Loadbiology.organism_classificationmedicine.diseaseHospitalsCross-Sectional StudiesInfectious DiseasesTanzaniaAnti-Retroviral AgentsChild PreschoolFamily medicineImmunologyFemaleVDP::Medical disciplines: 700::Health sciences: 800::Community medicine Social medicine: 801Rural areabusinessHIV infectionsmedicine.drugJournal of Antimicrobial Chemotherapy
researchProduct

Compensatory IgM to the Rescue: Patients with Selective IgA Deficiency Have Increased Natural IgM Antibodies to MAA-LDL and No Changes in Oral Microb…

2021

Abstract IgA is the most abundant Ab in the human body. However, most patients with selective IgA deficiency (SIgAD) are asymptomatic. IgM, and to lesser extent IgG Abs, are generally presumed to compensate for the lack of IgA in SIgAD by multiplying and adopting functions of IgA. We used data from the Northern Finland Birth Cohort 1966 to investigate whether SIgAD patients have differences in levels of natural Abs to oxidized epitopes compared with 20 randomly selected healthy controls. First, we screened the saliva and serum samples from the Northern Finland Birth Cohort 1966 cohort (n = 1610) for IgA concentration. We detected five IgA-deficient subjects, yielding a prevalence of 0.3%, w…

MaleSalivaImmunologySelective IgA deficiencyGut floraAsymptomaticEpitopesuuimmunologiaMalondialdehydeRNA Ribosomal 16SmedicineImmunology and AllergyHumanslimakalvotSalivaFinlandimmuunivajausoireyhtymätbiologyBacteriabusiness.industryvasta-aineetIgA DeficiencyGeneral MedicineMiddle Agedmedicine.diseasebiology.organism_classificationGastrointestinal MicrobiomeImmunoglobulin ALipoproteins LDLmikrobistoImmunoglobulin MCase-Control StudiesImmunoglobulin GImmunologyCohortBirth CohortFemale3111 Biomedicinemedicine.symptombusinessDysbiosisLipoproteinImmunoHorizons
researchProduct

Linking C5 deficiency to an exonic splicing enhancer mutation

2005

Abstract As an important component of the innate immune system, complement provides the initial response to prevent infections by pathogenic microorganisms. Patients with dysfunction of C5 display a propensity for severe recurrent infections. In this study, we present a patient with C5 deficiency demonstrated by immunochemical and functional analyses. Direct sequencing of all C5 exons displayed no mutation of obvious functional significance, except for an A to G transition in exon 10 predicting an exchange from lysine to arginine. This sequence alteration was present in only one allele of family members with a reduced serum C5 concentration and in both alleles of the patient with almost com…

MaleSequence analysisDNA Mutational AnalysisImmunologyExonic splicing enhancerBiologymedicine.disease_causeExonmedicineHumansImmunology and AllergyGeneFamily HealthGeneticsMutationSplice site mutationComplement C5ExonsSequence Analysis DNAC5 DeficiencyMolecular biologyAlternative SplicingPhenotypeChild PreschoolMutationRNA splicingThe Journal of Immunology
researchProduct

Molecular, genetic, and functional analysis of homozygous C8 beta-chain deficiency in two siblings.

1998

Abstract C8 deficiency is associated with an increased susceptibility to neisserial infections. We present a case of an 11 year old boy who suffered from infection with Neisseria meningitidis . Medical history of the patient and his family ( n = 5) did not indicate any previous immunodeficiency symptoms. Results from the analysis of phagocyte and lymphocyte functions were within the normal range. No hemolytic activities of the classical (CH50) and the alternative (APH50) pathways of complement were measurable, and SC5b-9 protein complexes could not be detected in the patient's plasma. Further analysis by highly sensitive ELISA and functional assays revealed a complete deficiency of C8. Upon…

MaleT-LymphocytesComplement Membrane Attack ComplexBiologyMeningitis Meningococcalmedicine.disease_causeAsymptomaticGenetic analysisComplement Hemolytic Activity AssayExonmedicineHumansMedical historyChildGeneImmunodeficiencyAllelesPharmacologyGeneticsBosnia and HerzegovinaMutationPhagocytesNeisseria meningitidisHomozygoteDNAExonsmedicine.diseaseComplement C8ImmunologyFemalemedicine.symptomImmunopharmacology
researchProduct

Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis.

2012

Introduction: This study aimed at defining protease (PR) resistance mutations associated with darunavir (DRV) failure and PR resistance evolution at DRV failure in a large database of treatment-experienced human immunodeficiency virus (HIV) patients. Results: Overall, 1,104 patients were included: 118 (10.7%) failed at a median observation time of 16 months. The mean number of PR mutations at baseline was 2.7, but it was higher in patients who subsequently failed DRV. In addition, the number of PR mutations increased at failure. The increase in the mean number of mutations was completely related to mutations considered to be associated with DRV resistance following the indications of the ma…

MaleTime FactorsCross-sectional studyHuman immunodeficiency virus (HIV)Drug ResistanceHIV InfectionsDrug resistancemedicine.disease_causeCohort StudiesAntiretroviral Therapy Highly ActiveRitonavir-boosted darunavirGenotypeHIV InfectionTreatment FailureViralGenotypic resistanceDarunavirSulfonamidesGeneral MedicineMiddle AgedVirological failureInfectious DiseasesFemaleHumanmedicine.drugAdultMicrobiology (medical)Logistic ModelTime FactorGenotypeAntiretroviral TherapySettore MED/17 - MALATTIE INFETTIVESulfonamideDrug Resistance ViralmedicineHumansHighly ActiveDarunavir; Genotypic resistance; Protease inhibitors; Ritonavir-boosted darunavir; Adult; Antiretroviral Therapy Highly Active; Cohort Studies; Cross-Sectional Studies; Female; Genotype; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Logistic Models; Male; Middle Aged; Mutation; Sulfonamides; Time Factors; Treatment Failure; Drug Resistance Viral; Microbiology (medical); Infectious DiseasesHIV Protease InhibitorDarunavirCross-Sectional Studiebusiness.industryHIV Protease InhibitorsProtease inhibitorsAntiretroviral therapyVirologyCross-Sectional StudiesLogistic ModelsProtease inhibitorMutationGenotypic resistanceHIV-1Cohort Studiebusiness
researchProduct

Changes in myocardial iron content following administration of intravenous iron (Myocardial‐IRON): Study design

2018

Treatment with intravenous ferric carboxymaltose (FCM) has been shown to improve symptoms, functional capacity, and quality of life in patients with heart failure and iron deficiency. However, the underlying mechanisms for these beneficial effects remain undetermined. The aim of this study is to quantify cardiac magnetic resonance changes in myocardial iron content after administration of intravenous FCM in patients with heart failure and iron deficiency and contrast them with parameters of heart failure severity. This is a multicenter, double-blind, randomized study. Fifty patients with stable symptomatic heart failure, left ventricular ejection fraction <50%, and iron deficiency will be r…

MaleTime FactorsMyocardial ironheart failure030204 cardiovascular system & hematologyFerric CompoundsSeverity of Illness IndexVentricular Function Left030218 nuclear medicine & medical imaginglaw.invention0302 clinical medicineiron deficiencyClinical ProtocolsQuality of lifeRandomized controlled triallawCardiac Magnetic Resonance Ferric Carboxymaltose Heart Failure Iron Deficiency Myocardial IronInfusions IntravenousEjection fractionAnemia Iron-DeficiencyGeneral MedicineIron deficiencyferric carboxymaltoseTreatment OutcomeResearch DesignCardiologyFemaleCardiology and Cardiovascular MedicineCardiac function curvemedicine.medical_specialtyTrial DesignsMagnetic Resonance Imaging CinePlacebocardiac magnetic resonance03 medical and health sciencesDouble-Blind MethodInternal medicinemedicineHumansMaltosemyocardial ironAgedHeart Failurebusiness.industryMyocardiumStroke VolumeRecovery of Functionmedicine.diseaseSpainHeart failureHematinicsQuality of Lifebusiness
researchProduct

Olfactory discrimination ability and brain expression of c-fos, Gir and Glut1 mRNA are altered in n-3 fatty acid-depleted rats

2007

Abstract The long-chain polyunsaturated n  − 3 fatty acids ( n  − 3 PUFA), particularly docosahexaenoic acid (DHA), are abundantly present in the central nervous system and play an important role in cognitive functions such as learning and memory. We, therefore, investigated the effects of n  − 3 PUFA-depletion in rats (F2 generation) on the learning of an olfactory discrimination task, progressively acquired within a four-arm maze, and on the mRNA expression of some candidate genes, i.e., c-fos, Gir and glucose transporter (Glut1), which could reflect the level of cerebral activity. We observed that DHA contents were dramatically decreased in the olfactory bulb, the piriform cortex and the…

MaleTime Factors[SDV]Life Sciences [q-bio]OLFACTORY LEARNINGReceptors G-Protein-CoupledDiscrimination LearningBehavioral Neuroscience0302 clinical medicineDiscrimination PsychologicalPiriform cortexBRAINDiet Fat-Restricted0303 health sciencesGlucose Transporter Type 1NeocortexBehavior AnimalGIRReverse Transcriptase Polymerase Chain ReactionSmellmedicine.anatomical_structureBiochemistryDocosahexaenoic acidN−3 DEFICIENCYOlfactory LearningProto-Oncogene Proteins c-fosmedicine.medical_specialtyN-3 PUFAC-FOSCentral nervous systemOlfactionBiologyAPPRENTISSAGE03 medical and health sciencesInternal medicineFatty Acids Omega-3medicineAnimalsRNA MessengerRats WistarUnsaturated fatty acid030304 developmental biologyAnalysis of VarianceBody WeightDOCOSAHEXAENOIC ACIDOlfactory bulbRatsEndocrinologyGene Expression RegulationRAT030217 neurology & neurosurgeryGLUT1
researchProduct